nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—PTGER3—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.0578	0.121	CbGpPWpGaD
Bimatoprost—PTGFR—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.0432	0.0905	CbGpPWpGaD
Bimatoprost—PTGER1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.0423	0.0885	CbGpPWpGaD
Bimatoprost—PTGER3—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.0401	0.0839	CbGpPWpGaD
Bimatoprost—PTGFR—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.03	0.0627	CbGpPWpGaD
Bimatoprost—PTGER1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.0293	0.0614	CbGpPWpGaD
Bimatoprost—AKR1C3—Podofilox—Etoposide—brain cancer	0.0287	1	CbGdCrCtD
Bimatoprost—Retinal haemorrhage—Procarbazine—brain cancer	0.0244	0.0603	CcSEcCtD
Bimatoprost—Conjunctival oedema—Carmustine—brain cancer	0.0179	0.0443	CcSEcCtD
Bimatoprost—AKR1C3—Arachidonic acid metabolism—CYP2C9—brain cancer	0.0156	0.0326	CbGpPWpGaD
Bimatoprost—Retinal haemorrhage—Carmustine—brain cancer	0.0152	0.0378	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Procarbazine—brain cancer	0.0134	0.0331	CcSEcCtD
Bimatoprost—Epoprostenol—CYP2C9—brain cancer	0.0117	1	CrCbGaD
Bimatoprost—Skin hyperpigmentation—Hydroxyurea—brain cancer	0.0103	0.0256	CcSEcCtD
Bimatoprost—Blepharitis—Hydroxyurea—brain cancer	0.00999	0.0247	CcSEcCtD
Bimatoprost—Visual disturbance—Lomustine—brain cancer	0.00958	0.0237	CcSEcCtD
Bimatoprost—PTGER3—telencephalon—brain cancer	0.00869	0.112	CbGeAlD
Bimatoprost—Skin hyperpigmentation—Carmustine—brain cancer	0.00835	0.0207	CcSEcCtD
Bimatoprost—Photophobia—Procarbazine—brain cancer	0.00746	0.0185	CcSEcCtD
Bimatoprost—Burning sensation—Carmustine—brain cancer	0.00715	0.0177	CcSEcCtD
Bimatoprost—Scotoma—Carmustine—brain cancer	0.00654	0.0162	CcSEcCtD
Bimatoprost—Scotoma—Temozolomide—brain cancer	0.00632	0.0157	CcSEcCtD
Bimatoprost—PTGER1—endocrine gland—brain cancer	0.00625	0.0802	CbGeAlD
Bimatoprost—PTGER1—head—brain cancer	0.00617	0.0792	CbGeAlD
Bimatoprost—Visual impairment—Lomustine—brain cancer	0.00605	0.015	CcSEcCtD
Bimatoprost—Diplopia—Procarbazine—brain cancer	0.00577	0.0143	CcSEcCtD
Bimatoprost—AKR1C3—Metapathway biotransformation—CYP2C9—brain cancer	0.00572	0.012	CbGpPWpGaD
Bimatoprost—PTGER1—central nervous system—brain cancer	0.00563	0.0723	CbGeAlD
Bimatoprost—PTGFR—GPCRs, Other—SMO—brain cancer	0.0056	0.0117	CbGpPWpGaD
Bimatoprost—PTGER3—endocrine gland—brain cancer	0.00548	0.0704	CbGeAlD
Bimatoprost—PTGER3—head—brain cancer	0.00541	0.0695	CbGeAlD
Bimatoprost—Infection—Carboplatin—brain cancer	0.00507	0.0126	CcSEcCtD
Bimatoprost—PTGER3—central nervous system—brain cancer	0.00494	0.0634	CbGeAlD
Bimatoprost—AKR1C3—pituitary gland—brain cancer	0.0046	0.059	CbGeAlD
Bimatoprost—Dry eye—Temozolomide—brain cancer	0.00444	0.011	CcSEcCtD
Bimatoprost—AKR1C3—medulla oblongata—brain cancer	0.00443	0.0569	CbGeAlD
Bimatoprost—Infection—Lomustine—brain cancer	0.00443	0.011	CcSEcCtD
Bimatoprost—PTGFR—endocrine gland—brain cancer	0.00438	0.0562	CbGeAlD
Bimatoprost—Pain—Carboplatin—brain cancer	0.00436	0.0108	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—PTCH2—brain cancer	0.00435	0.00909	CbGpPWpGaD
Bimatoprost—PTGFR—head—brain cancer	0.00433	0.0555	CbGeAlD
Bimatoprost—Skin discolouration—Etoposide—brain cancer	0.00425	0.0105	CcSEcCtD
Bimatoprost—AKR1C3—midbrain—brain cancer	0.00405	0.052	CbGeAlD
Bimatoprost—Eye pain—Carmustine—brain cancer	0.004	0.00989	CcSEcCtD
Bimatoprost—Inflammation—Etoposide—brain cancer	0.00396	0.00981	CcSEcCtD
Bimatoprost—AKR1C3—spinal cord—brain cancer	0.00395	0.0508	CbGeAlD
Bimatoprost—PTGER3—brain—brain cancer	0.00392	0.0503	CbGeAlD
Bimatoprost—Eye pain—Temozolomide—brain cancer	0.00386	0.00956	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—OR4C12—brain cancer	0.00381	0.00798	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—OR14C36—brain cancer	0.00381	0.00798	CbGpPWpGaD
Bimatoprost—Diplopia—Carmustine—brain cancer	0.00361	0.00893	CcSEcCtD
Bimatoprost—Diplopia—Temozolomide—brain cancer	0.00349	0.00863	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—OR14C36—brain cancer	0.00346	0.00724	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—OR4C12—brain cancer	0.00346	0.00724	CbGpPWpGaD
Bimatoprost—Tension—Procarbazine—brain cancer	0.00341	0.00844	CcSEcCtD
Bimatoprost—Nervousness—Procarbazine—brain cancer	0.00337	0.00835	CcSEcCtD
Bimatoprost—Liver function test abnormal—Carmustine—brain cancer	0.00333	0.00825	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—PTCH2—brain cancer	0.00325	0.0068	CbGpPWpGaD
Bimatoprost—PTGFR—G alpha (q) signalling events—TRPC6—brain cancer	0.0032	0.0067	CbGpPWpGaD
Bimatoprost—Dry skin—Temozolomide—brain cancer	0.0032	0.00791	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—PTCH2—brain cancer	0.00318	0.00666	CbGpPWpGaD
Bimatoprost—AKR1C3—cerebellum—brain cancer	0.00314	0.0403	CbGeAlD
Bimatoprost—PTGER1—G alpha (q) signalling events—TRPC6—brain cancer	0.00313	0.00656	CbGpPWpGaD
Bimatoprost—Cough—Procarbazine—brain cancer	0.00303	0.0075	CcSEcCtD
Bimatoprost—Hypertension—Procarbazine—brain cancer	0.003	0.00742	CcSEcCtD
Bimatoprost—Anxiety—Procarbazine—brain cancer	0.00295	0.00729	CcSEcCtD
Bimatoprost—Bronchitis—Temozolomide—brain cancer	0.0029	0.00717	CcSEcCtD
Bimatoprost—Dry mouth—Procarbazine—brain cancer	0.00289	0.00716	CcSEcCtD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.00286	0.00599	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—OR4C12—brain cancer	0.00285	0.00596	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—OR14C36—brain cancer	0.00285	0.00596	CbGpPWpGaD
Bimatoprost—Infection—Procarbazine—brain cancer	0.00282	0.00697	CcSEcCtD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.0028	0.00586	CbGpPWpGaD
Bimatoprost—Angiopathy—Hydroxyurea—brain cancer	0.0028	0.00693	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Temozolomide—brain cancer	0.0028	0.00693	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—OR4C12—brain cancer	0.00279	0.00584	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—OR14C36—brain cancer	0.00279	0.00584	CbGpPWpGaD
Bimatoprost—Depression—Carmustine—brain cancer	0.00277	0.00686	CcSEcCtD
Bimatoprost—Erythema—Hydroxyurea—brain cancer	0.00269	0.00665	CcSEcCtD
Bimatoprost—Depression—Temozolomide—brain cancer	0.00268	0.00663	CcSEcCtD
Bimatoprost—Nausea—Lomustine—brain cancer	0.00265	0.00656	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—OR14C36—brain cancer	0.00259	0.00542	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—OR4C12—brain cancer	0.00259	0.00542	CbGpPWpGaD
Bimatoprost—Insomnia—Procarbazine—brain cancer	0.00256	0.00635	CcSEcCtD
Bimatoprost—AKR1C3—brain—brain cancer	0.00255	0.0327	CbGeAlD
Bimatoprost—PTGER1—Signaling by GPCR—OR4C12—brain cancer	0.00253	0.0053	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—OR14C36—brain cancer	0.00253	0.0053	CbGpPWpGaD
Bimatoprost—Sinusitis—Temozolomide—brain cancer	0.00252	0.00624	CcSEcCtD
Bimatoprost—Somnolence—Procarbazine—brain cancer	0.00252	0.00624	CcSEcCtD
Bimatoprost—Oedema peripheral—Carmustine—brain cancer	0.00246	0.00609	CcSEcCtD
Bimatoprost—Connective tissue disorder—Carmustine—brain cancer	0.00245	0.00607	CcSEcCtD
Bimatoprost—Pain—Procarbazine—brain cancer	0.00242	0.006	CcSEcCtD
Bimatoprost—Visual impairment—Carmustine—brain cancer	0.0024	0.00595	CcSEcCtD
Bimatoprost—Pharyngitis—Temozolomide—brain cancer	0.00239	0.00593	CcSEcCtD
Bimatoprost—Oedema peripheral—Temozolomide—brain cancer	0.00238	0.00588	CcSEcCtD
Bimatoprost—Connective tissue disorder—Temozolomide—brain cancer	0.00237	0.00587	CcSEcCtD
Bimatoprost—Eye disorder—Carmustine—brain cancer	0.00233	0.00577	CcSEcCtD
Bimatoprost—Visual impairment—Temozolomide—brain cancer	0.00232	0.00575	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00227	0.00563	CcSEcCtD
Bimatoprost—Eye disorder—Temozolomide—brain cancer	0.00225	0.00558	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—SHH—brain cancer	0.00224	0.00469	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—PTCH2—brain cancer	0.00223	0.00467	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00223	0.00466	CbGpPWpGaD
Bimatoprost—Angiopathy—Temozolomide—brain cancer	0.00219	0.00542	CcSEcCtD
Bimatoprost—Infection—Hydroxyurea—brain cancer	0.00218	0.0054	CcSEcCtD
Bimatoprost—Mediastinal disorder—Temozolomide—brain cancer	0.00217	0.00538	CcSEcCtD
Bimatoprost—Erythema—Carmustine—brain cancer	0.00217	0.00538	CcSEcCtD
Bimatoprost—Nervous system disorder—Hydroxyurea—brain cancer	0.00215	0.00533	CcSEcCtD
Bimatoprost—Skin disorder—Hydroxyurea—brain cancer	0.00213	0.00527	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—SMO—brain cancer	0.00212	0.00444	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—PTCH1—brain cancer	0.00212	0.00444	CbGpPWpGaD
Bimatoprost—Erythema—Temozolomide—brain cancer	0.0021	0.0052	CcSEcCtD
Bimatoprost—Vision blurred—Carmustine—brain cancer	0.00205	0.00507	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—OR14C36—brain cancer	0.00204	0.00428	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—OR4C12—brain cancer	0.00204	0.00428	CbGpPWpGaD
Bimatoprost—Asthenia—Procarbazine—brain cancer	0.00203	0.00503	CcSEcCtD
Bimatoprost—Pruritus—Procarbazine—brain cancer	0.002	0.00496	CcSEcCtD
Bimatoprost—Vision blurred—Temozolomide—brain cancer	0.00198	0.0049	CcSEcCtD
Bimatoprost—Dyspnoea—Hydroxyurea—brain cancer	0.00196	0.00484	CcSEcCtD
Bimatoprost—Somnolence—Hydroxyurea—brain cancer	0.00195	0.00483	CcSEcCtD
Bimatoprost—Dyspepsia—Hydroxyurea—brain cancer	0.00193	0.00478	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—ABR—brain cancer	0.00193	0.00403	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00189	0.00469	CcSEcCtD
Bimatoprost—Vertigo—Temozolomide—brain cancer	0.00189	0.00467	CcSEcCtD
Bimatoprost—Hypertension—Carmustine—brain cancer	0.00188	0.00464	CcSEcCtD
Bimatoprost—Pain—Hydroxyurea—brain cancer	0.00188	0.00464	CcSEcCtD
Bimatoprost—Dizziness—Procarbazine—brain cancer	0.00187	0.00464	CcSEcCtD
Bimatoprost—Palpitations—Temozolomide—brain cancer	0.00186	0.00459	CcSEcCtD
Bimatoprost—Chest pain—Carmustine—brain cancer	0.00185	0.00458	CcSEcCtD
Bimatoprost—Anxiety—Carmustine—brain cancer	0.00184	0.00456	CcSEcCtD
Bimatoprost—Cough—Temozolomide—brain cancer	0.00183	0.00454	CcSEcCtD
Bimatoprost—Hypertension—Temozolomide—brain cancer	0.00181	0.00449	CcSEcCtD
Bimatoprost—Eye disorder—Etoposide—brain cancer	0.0018	0.00447	CcSEcCtD
Bimatoprost—Rash—Procarbazine—brain cancer	0.00179	0.00442	CcSEcCtD
Bimatoprost—Dermatitis—Procarbazine—brain cancer	0.00179	0.00442	CcSEcCtD
Bimatoprost—Anxiety—Temozolomide—brain cancer	0.00178	0.00441	CcSEcCtD
Bimatoprost—Headache—Procarbazine—brain cancer	0.00178	0.0044	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00177	0.00439	CcSEcCtD
Bimatoprost—Infection—Carmustine—brain cancer	0.00176	0.00436	CcSEcCtD
Bimatoprost—AKR1C3—Disease—DTX2—brain cancer	0.00175	0.00367	CbGpPWpGaD
Bimatoprost—Angiopathy—Etoposide—brain cancer	0.00175	0.00434	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—ABR—brain cancer	0.00175	0.00366	CbGpPWpGaD
Bimatoprost—Dry mouth—Temozolomide—brain cancer	0.00175	0.00433	CcSEcCtD
Bimatoprost—Mediastinal disorder—Etoposide—brain cancer	0.00174	0.00431	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—DTX2—brain cancer	0.00174	0.00364	CbGpPWpGaD
Bimatoprost—Infection—Temozolomide—brain cancer	0.0017	0.00421	CcSEcCtD
Bimatoprost—Nausea—Procarbazine—brain cancer	0.00168	0.00417	CcSEcCtD
Bimatoprost—Nervous system disorder—Temozolomide—brain cancer	0.00168	0.00416	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—SHH—brain cancer	0.00167	0.0035	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PTCH2—brain cancer	0.00167	0.00349	CbGpPWpGaD
Bimatoprost—Skin disorder—Temozolomide—brain cancer	0.00166	0.00412	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—SHH—brain cancer	0.00164	0.00343	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PTCH2—brain cancer	0.00163	0.00342	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.00163	0.00341	CbGpPWpGaD
Bimatoprost—Insomnia—Carmustine—brain cancer	0.0016	0.00397	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—PTCH1—brain cancer	0.00159	0.00332	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—SMO—brain cancer	0.00159	0.00332	CbGpPWpGaD
Bimatoprost—Dyspnoea—Carmustine—brain cancer	0.00158	0.00391	CcSEcCtD
Bimatoprost—Somnolence—Carmustine—brain cancer	0.00158	0.0039	CcSEcCtD
Bimatoprost—Asthenia—Hydroxyurea—brain cancer	0.00157	0.0039	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—PTCH1—brain cancer	0.00155	0.00325	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—SMO—brain cancer	0.00155	0.00325	CbGpPWpGaD
Bimatoprost—Insomnia—Temozolomide—brain cancer	0.00155	0.00384	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Carmustine—brain cancer	0.00153	0.00379	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—OR14C36—brain cancer	0.00153	0.0032	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—OR4C12—brain cancer	0.00153	0.0032	CbGpPWpGaD
Bimatoprost—Dyspnoea—Temozolomide—brain cancer	0.00153	0.00378	CcSEcCtD
Bimatoprost—Somnolence—Temozolomide—brain cancer	0.00152	0.00377	CcSEcCtD
Bimatoprost—Pain—Carmustine—brain cancer	0.00152	0.00375	CcSEcCtD
Bimatoprost—Vertigo—Etoposide—brain cancer	0.00151	0.00374	CcSEcCtD
Bimatoprost—Dyspepsia—Temozolomide—brain cancer	0.00151	0.00373	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—OR4C12—brain cancer	0.0015	0.00313	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—OR14C36—brain cancer	0.0015	0.00313	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Temozolomide—brain cancer	0.00148	0.00366	CcSEcCtD
Bimatoprost—Cough—Etoposide—brain cancer	0.00147	0.00363	CcSEcCtD
Bimatoprost—Pain—Temozolomide—brain cancer	0.00147	0.00363	CcSEcCtD
Bimatoprost—Hypertension—Etoposide—brain cancer	0.00145	0.00359	CcSEcCtD
Bimatoprost—Dizziness—Hydroxyurea—brain cancer	0.00145	0.00359	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—OR14C36—brain cancer	0.00144	0.00302	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—OR4C12—brain cancer	0.00144	0.00302	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—ABR—brain cancer	0.00144	0.00302	CbGpPWpGaD
Bimatoprost—Chest pain—Etoposide—brain cancer	0.00143	0.00354	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00142	0.00352	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—ABR—brain cancer	0.00141	0.00295	CbGpPWpGaD
Bimatoprost—Rash—Hydroxyurea—brain cancer	0.00138	0.00342	CcSEcCtD
Bimatoprost—Dermatitis—Hydroxyurea—brain cancer	0.00138	0.00342	CcSEcCtD
Bimatoprost—Headache—Hydroxyurea—brain cancer	0.00137	0.0034	CcSEcCtD
Bimatoprost—Infection—Etoposide—brain cancer	0.00136	0.00337	CcSEcCtD
Bimatoprost—Skin disorder—Etoposide—brain cancer	0.00133	0.0033	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—PTCH2—brain cancer	0.00132	0.00276	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—ABR—brain cancer	0.00131	0.00274	CbGpPWpGaD
Bimatoprost—Nausea—Hydroxyurea—brain cancer	0.0013	0.00323	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—DTX2—brain cancer	0.0013	0.00272	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—HES5—brain cancer	0.00129	0.00269	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—ABR—brain cancer	0.00128	0.00268	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HES5—brain cancer	0.00128	0.00267	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—DTX2—brain cancer	0.00127	0.00266	CbGpPWpGaD
Bimatoprost—Asthenia—Carmustine—brain cancer	0.00127	0.00315	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—STRADA—brain cancer	0.00124	0.00259	CbGpPWpGaD
Bimatoprost—Asthenia—Temozolomide—brain cancer	0.00123	0.00304	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—DTX2—brain cancer	0.00123	0.00257	CbGpPWpGaD
Bimatoprost—Dyspnoea—Etoposide—brain cancer	0.00122	0.00303	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—TRPC6—brain cancer	0.00122	0.00255	CbGpPWpGaD
Bimatoprost—Somnolence—Etoposide—brain cancer	0.00122	0.00302	CcSEcCtD
Bimatoprost—Pruritus—Temozolomide—brain cancer	0.00121	0.003	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Etoposide—brain cancer	0.00118	0.00293	CcSEcCtD
Bimatoprost—Dizziness—Carmustine—brain cancer	0.00117	0.0029	CcSEcCtD
Bimatoprost—Pain—Etoposide—brain cancer	0.00117	0.0029	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—SHH—brain cancer	0.00115	0.0024	CbGpPWpGaD
Bimatoprost—Dizziness—Temozolomide—brain cancer	0.00113	0.00281	CcSEcCtD
Bimatoprost—Rash—Carmustine—brain cancer	0.00112	0.00277	CcSEcCtD
Bimatoprost—Dermatitis—Carmustine—brain cancer	0.00112	0.00277	CcSEcCtD
Bimatoprost—Headache—Carmustine—brain cancer	0.00111	0.00275	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—TRPC6—brain cancer	0.00111	0.00232	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—PTCH1—brain cancer	0.00109	0.00228	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—SMO—brain cancer	0.00109	0.00228	CbGpPWpGaD
Bimatoprost—Rash—Temozolomide—brain cancer	0.00108	0.00267	CcSEcCtD
Bimatoprost—Dermatitis—Temozolomide—brain cancer	0.00108	0.00267	CcSEcCtD
Bimatoprost—Headache—Temozolomide—brain cancer	0.00107	0.00266	CcSEcCtD
Bimatoprost—Nausea—Carmustine—brain cancer	0.00105	0.00261	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—ABR—brain cancer	0.00103	0.00216	CbGpPWpGaD
Bimatoprost—Nausea—Temozolomide—brain cancer	0.00102	0.00252	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—GLI2—brain cancer	0.000999	0.00209	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CYP2C9—brain cancer	0.000992	0.00208	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTCH2—brain cancer	0.000985	0.00206	CbGpPWpGaD
Bimatoprost—Asthenia—Etoposide—brain cancer	0.000984	0.00244	CcSEcCtD
Bimatoprost—Pruritus—Etoposide—brain cancer	0.00097	0.0024	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—PTCH2—brain cancer	0.000964	0.00202	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HES5—brain cancer	0.000954	0.002	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—GLI1—brain cancer	0.000939	0.00196	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HES5—brain cancer	0.000934	0.00195	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTCH2—brain cancer	0.00093	0.00195	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—STRADA—brain cancer	0.000926	0.00194	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—VAV1—brain cancer	0.000914	0.00191	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—TRPC6—brain cancer	0.000912	0.00191	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—STRADA—brain cancer	0.000907	0.0019	CbGpPWpGaD
Bimatoprost—Dizziness—Etoposide—brain cancer	0.000907	0.00224	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—HES5—brain cancer	0.000901	0.00189	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—TRPC6—brain cancer	0.000893	0.00187	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SUFU—brain cancer	0.00089	0.00186	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—STRADA—brain cancer	0.000875	0.00183	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IDH1—brain cancer	0.000866	0.00181	CbGpPWpGaD
Bimatoprost—Rash—Etoposide—brain cancer	0.000864	0.00214	CcSEcCtD
Bimatoprost—Dermatitis—Etoposide—brain cancer	0.000864	0.00214	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—SHH—brain cancer	0.000859	0.0018	CbGpPWpGaD
Bimatoprost—Headache—Etoposide—brain cancer	0.000859	0.00213	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—GFAP—brain cancer	0.000859	0.0018	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—BSG—brain cancer	0.000843	0.00176	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—SHH—brain cancer	0.000841	0.00176	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—VAV1—brain cancer	0.00083	0.00174	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—TRPC6—brain cancer	0.000829	0.00173	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—HEY1—brain cancer	0.000821	0.00172	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PTCH1—brain cancer	0.000815	0.0017	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—SMO—brain cancer	0.000815	0.0017	CbGpPWpGaD
Bimatoprost—Nausea—Etoposide—brain cancer	0.000814	0.00202	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—HEY1—brain cancer	0.000814	0.0017	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—TRPC6—brain cancer	0.000811	0.0017	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—DLL1—brain cancer	0.000805	0.00168	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—DLL1—brain cancer	0.000798	0.00167	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PTCH1—brain cancer	0.000797	0.00167	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—SMO—brain cancer	0.000797	0.00167	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ABR—brain cancer	0.000773	0.00162	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ABR—brain cancer	0.000757	0.00158	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GLI2—brain cancer	0.000747	0.00156	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000733	0.00153	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GLI2—brain cancer	0.000731	0.00153	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ABR—brain cancer	0.00073	0.00153	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—IDH1—brain cancer	0.000725	0.00152	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000718	0.0015	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GLI2—brain cancer	0.000705	0.00148	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GLI1—brain cancer	0.000702	0.00147	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GLI1—brain cancer	0.000687	0.00144	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SHH—brain cancer	0.000684	0.00143	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—ENO2—brain cancer	0.000684	0.00143	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—VAV1—brain cancer	0.000684	0.00143	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SHH—brain cancer	0.000679	0.00142	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—VAV1—brain cancer	0.000669	0.0014	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SUFU—brain cancer	0.000666	0.00139	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GLI1—brain cancer	0.000663	0.00139	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TRPC6—brain cancer	0.000655	0.00137	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SUFU—brain cancer	0.000651	0.00136	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SMO—brain cancer	0.000643	0.00135	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PTCH1—brain cancer	0.000643	0.00135	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GFAP—brain cancer	0.000642	0.00134	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SUFU—brain cancer	0.000629	0.00132	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GFAP—brain cancer	0.000629	0.00132	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—VAV1—brain cancer	0.000621	0.0013	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HEY1—brain cancer	0.000609	0.00127	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—VAV1—brain cancer	0.000608	0.00127	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GFAP—brain cancer	0.000606	0.00127	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—DLL1—brain cancer	0.000597	0.00125	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HEY1—brain cancer	0.000596	0.00125	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.00059	0.00124	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—DLL1—brain cancer	0.000584	0.00122	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—PIK3CG—brain cancer	0.00058	0.00121	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HEY1—brain cancer	0.000575	0.0012	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ENO2—brain cancer	0.000573	0.0012	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—DLL1—brain cancer	0.000564	0.00118	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—PIK3CG—brain cancer	0.000527	0.0011	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NOTCH2—brain cancer	0.000514	0.00108	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SHH—brain cancer	0.000508	0.00106	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SHH—brain cancer	0.000497	0.00104	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—VAV1—brain cancer	0.000495	0.00103	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—VAV1—brain cancer	0.00049	0.00103	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TRPC6—brain cancer	0.000489	0.00102	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTCH1—brain cancer	0.000481	0.00101	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SMO—brain cancer	0.000481	0.00101	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SHH—brain cancer	0.000479	0.001	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TRPC6—brain cancer	0.000479	0.001	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTCH1—brain cancer	0.000471	0.000986	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SMO—brain cancer	0.000471	0.000986	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TRPC6—brain cancer	0.000462	0.000967	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTCH1—brain cancer	0.000454	0.000951	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SMO—brain cancer	0.000454	0.000951	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—PIK3CG—brain cancer	0.000434	0.000908	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—HES1—brain cancer	0.000425	0.00089	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PIK3CG—brain cancer	0.000425	0.000889	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HES1—brain cancer	0.000422	0.000883	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—IL2—brain cancer	0.000408	0.000855	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PDGFRA—brain cancer	0.000405	0.000847	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PDGFRA—brain cancer	0.000402	0.00084	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CG—brain cancer	0.000394	0.000825	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SPP1—brain cancer	0.00039	0.000816	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CG—brain cancer	0.000386	0.000807	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NOTCH2—brain cancer	0.000385	0.000805	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NOTCH2—brain cancer	0.000377	0.000788	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL2—brain cancer	0.000371	0.000776	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—VAV1—brain cancer	0.000367	0.000767	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOTCH2—brain cancer	0.000363	0.00076	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—VAV1—brain cancer	0.000359	0.000751	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IRS2—brain cancer	0.000356	0.000744	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IRS2—brain cancer	0.000353	0.000738	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—VAV1—brain cancer	0.000346	0.000725	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HES1—brain cancer	0.000315	0.00066	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—APC—brain cancer	0.000314	0.000657	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—APC—brain cancer	0.000311	0.000652	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CG—brain cancer	0.000311	0.000652	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HES1—brain cancer	0.000309	0.000646	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—IL2—brain cancer	0.000305	0.000639	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PDGFRA—brain cancer	0.0003	0.000628	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—IL2—brain cancer	0.000299	0.000626	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HES1—brain cancer	0.000298	0.000623	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PDGFRA—brain cancer	0.000294	0.000615	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SPP1—brain cancer	0.000292	0.00061	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SPP1—brain cancer	0.000285	0.000597	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—EGFR—brain cancer	0.000284	0.000594	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PDGFRA—brain cancer	0.000284	0.000593	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL2—brain cancer	0.000277	0.00058	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SPP1—brain cancer	0.000275	0.000576	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL2—brain cancer	0.000271	0.000568	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IRS2—brain cancer	0.000264	0.000552	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CG—brain cancer	0.000263	0.00055	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IRS2—brain cancer	0.000258	0.00054	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IRS2—brain cancer	0.000249	0.000521	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—ERBB2—brain cancer	0.000244	0.00051	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RELA—brain cancer	0.000243	0.000509	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ERBB2—brain cancer	0.000242	0.000506	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APC—brain cancer	0.000233	0.000487	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CG—brain cancer	0.000233	0.000487	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CG—brain cancer	0.000228	0.000477	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APC—brain cancer	0.000228	0.000477	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CG—brain cancer	0.00022	0.00046	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APC—brain cancer	0.00022	0.00046	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL2—brain cancer	0.000219	0.000459	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCND1—brain cancer	0.000214	0.000447	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CTNNB1—brain cancer	0.000213	0.000446	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—EGFR—brain cancer	0.000212	0.000444	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CTNNB1—brain cancer	0.000212	0.000443	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—EGFR—brain cancer	0.000208	0.000434	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—VEGFA—brain cancer	0.000186	0.00039	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—STAT3—brain cancer	0.000186	0.000389	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—STAT3—brain cancer	0.000184	0.000386	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RELA—brain cancer	0.000182	0.000381	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ERBB2—brain cancer	0.000181	0.000378	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RELA—brain cancer	0.000178	0.000373	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ERBB2—brain cancer	0.000177	0.00037	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MYC—brain cancer	0.000173	0.000362	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RELA—brain cancer	0.000172	0.00036	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MYC—brain cancer	0.000171	0.000359	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ERBB2—brain cancer	0.000171	0.000357	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—EGFR—brain cancer	0.000169	0.000354	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EGFR—brain cancer	0.000168	0.000351	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL2—brain cancer	0.000164	0.000343	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL2—brain cancer	0.00016	0.000336	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCND1—brain cancer	0.00016	0.000334	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CTNNB1—brain cancer	0.000158	0.000331	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCND1—brain cancer	0.000156	0.000327	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CTNNB1—brain cancer	0.000155	0.000324	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL2—brain cancer	0.000155	0.000324	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCND1—brain cancer	0.000151	0.000316	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CTNNB1—brain cancer	0.000149	0.000313	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TP53—brain cancer	0.000141	0.000294	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—VEGFA—brain cancer	0.000139	0.000291	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—STAT3—brain cancer	0.000138	0.000289	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—VEGFA—brain cancer	0.000136	0.000285	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—STAT3—brain cancer	0.000135	0.000282	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—VEGFA—brain cancer	0.000132	0.000275	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—STAT3—brain cancer	0.00013	0.000272	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MYC—brain cancer	0.000128	0.000268	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MYC—brain cancer	0.000125	0.000262	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EGFR—brain cancer	0.000125	0.000262	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EGFR—brain cancer	0.000123	0.000257	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MYC—brain cancer	0.000121	0.000253	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EGFR—brain cancer	0.000118	0.000248	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TP53—brain cancer	0.000105	0.00022	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TP53—brain cancer	0.000103	0.000216	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TP53—brain cancer	9.94e-05	0.000208	CbGpPWpGaD
